Acadia Healthcare Company
Stock Forecast, Prediction & Price Target
Acadia Healthcare Company (ACHC) stock Price Target by analysts
$81.5
Potential upside: 267.44%
Acadia Healthcare Company price prediction
What is Acadia Healthcare Company stock analysts` prediction?
Acadia Healthcare Company stock forecast: Based on 2 Wall Street analysts` predicted price targets for Acadia Healthcare Company in the last 3 months, the avarage price target is $81.5, with a high forecast of $NaN. The average price target represents a 267.44% change from the last price of $22.18.
Disclaimer: This is not investment advice. Don't use price targets as the only investment indicator. Always remember to do your own thorough research and due diligence before making an investment decision.
Acadia Healthcare Company stock Price Target by analysts
Full breakdown of analysts given Acadia Healthcare Company price targets
| Analyst name & company | Analyst win rate | Publish date | Price target | Price when posted | Source | Historical targets |
|---|---|---|---|---|---|---|
Whit Mayo Leerink Partners | 0% 0/1 | 11 months ago | $87 292.24% upside | $52.03 | StreetInsider | Previous targets (0) |
Andrew Mok Barclays | 0% 0/2 | about 1 year ago | $76 242.65% upside | $63.87 | TheFly | Previous targets (1) |
Andrew Mok Barclays | 0% 0/2 | about 1 year ago | $83 274.21% upside | $64.85 | TheFly | Previous targets (1) |
Frank Morgan RBC Capital | 0% 0/1 | over 1 year ago | $94 323.80% upside | $66.64 | StreetInsider | Previous targets (0) |
Ann Hynes Mizuho Securities | 0% 0/1 | over 1 year ago | $70 215.59% upside | $66.73 | StreetInsider | Previous targets (0) |
Pito Chickering Deutsche Bank | 100% 1/1 | over 1 year ago | $70 215.59% upside | $71.19 | StreetInsider | Previous targets (0) |
Unknown RBC Capital | N/A | almost 3 years ago | $93 319.29% upside | $82.25 | Benzinga | N/A |
Unknown Leerink Partners | N/A | about 3 years ago | $103 364.38% upside | $85.23 | Benzinga | N/A |
Unknown RBC Capital | N/A | about 3 years ago | $94 323.80% upside | $82.91 | Benzinga | N/A |
Unknown Raymond James | N/A | about 3 years ago | $100 350.85% upside | $82.91 | Benzinga | N/A |
Unknown Barclays | N/A | about 3 years ago | $85 283.22% upside | $80.93 | Benzinga | N/A |
Unknown Mizuho Securities | N/A | about 3 years ago | $78 251.66% upside | $80.91 | Benzinga | N/A |
Unknown UBS | N/A | about 3 years ago | $90 305.77% upside | $79.94 | Benzinga | N/A |
Joseph France Loop Capital Markets | 100% 1/1 | over 3 years ago | $72 224.61% upside | $64.9 | Pulse 2.0 | Previous targets (0) |
Kevin Fischbeck Bank of America Securities | 100% 1/1 | about 4 years ago | $82 269.70% upside | $63.62 | StreetInsider | Previous targets (0) |
Acadia Healthcare Company Financial Estimates
Acadia Healthcare Company Revenue Estimates
Acadia Healthcare Company EBITDA Estimates
Acadia Healthcare Company Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | |
Revenue
% change YoY
| $2.31B N/A | $2.61B 12.78% | $2.92B 12.19% | Avg: $3.52B Low: $3.47B High: $3.62B avg. 20.39% | Avg: $3.89B Low: $3.85B High: $3.96B avg. 10.38% | Avg: $4.38B Low: $4.33B High: $4.46B avg. 12.60% | |
Net Income
% change YoY
| $190.63M N/A | $273.13M 43.27% | $-21.66M -107.93% | Avg: $365.48M Low: $338.33M High: $364.70M avg. 1786.83% | Avg: $421.06M Low: $379.25M High: $442.01M avg. 15.20% | Avg: $507.49M Low: $500.76M High: $520.49M avg. 20.52% | |
EBITDA
% change YoY
| $521.19M N/A | $561.67M 7.76% | $189.11M -66.33% | Avg: $748.93M Low: $738.32M High: $770.15M avg. 296.02% | Avg: $826.71M Low: $818.27M High: $843.01M avg. 10.38% | Avg: $930.89M Low: $921.39M High: $949.24M avg. 12.60% | |
EPS
% change YoY
| $2.3 N/A | $3.05 32.60% | -$0.24 -107.86% | Avg: $3.87 Low: $3.72 High: $4.01 avg. 1712.50% | Avg: $4.5 Low: $4.17 High: $4.86 avg. 16.36% | Avg: $5.58 Low: $5.51 High: $5.72 avg. 23.90% | |
Operating Expenses
% change YoY
| $565.41M N/A | $649.07M 14.79% | $176.01M -72.88% | Avg: $277.36M Low: $273.43M High: $285.22M avg. 57.58% | Avg: $306.17M Low: $303.04M High: $312.20M avg. 10.38% | Avg: $344.75M Low: $341.23M High: $351.54M avg. 12.60% | |
FAQ
What is Acadia Healthcare Company stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 607.52% in 2025-2027.
We have gathered data from 7 analysts. Their low estimate is 338.33M, average is 365.48M and high is 364.70M.
What is Acadia Healthcare Company stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 14.46% in 2025-2027.
We have gathered data from 9 analysts. Their low revenue estimate is $3.47B, average is $3.52B and high is $3.62B.
What is Acadia Healthcare Company stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 584.25% in 2025-2027.
We have gathered data from 7 analysts. Their low earnings per share estimate is $3.72, average is $3.87 and high is $4.01.
What is the best performing analyst?
In the last twelve months 2 analysts have been covering Acadia Healthcare Company stock. The most successful analyst is Whit Mayo.